Furthermore, in pan-cancer and in seven individual cancer types, the ratios of immune-stimulatory to immune-inhibitory signatures (CD8+ T cells/PD-1) were significantly lower in SFG-mutated than in SFG-wildtype tumors (p < .05) (Figure 3B). The gene discussed is CD8A; the disease is cancer.